logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Gastroesophageal Reflux

    Medications for Gastroesophageal Reflux

    FiltersReset Filters
    30 results

    • cimetidine

      (cimetidine)
      Bionpharma Inc.
      Usage: Cimetidine tablets are indicated for the short-term treatment of active duodenal and benign gastric ulcers, maintenance therapy for healed duodenal ulcers, erosive gastroesophageal reflux (GERD), and pathological hypersecretory conditions like Zollinger-Ellison Syndrome. Treatment durations typically do not exceed 8 to 12 weeks.

    • esomeprazole magnesium

      (Esomeprazole magnesium delayed release capsules)
      Ascend Laboratories, LLC
      Usage: Esomeprazole magnesium delayed-release capsules are indicated for the healing and maintenance of erosive esophagitis, treatment of symptomatic GERD, gastric ulcer risk reduction from NSAID therapy, H. pylori eradication, and long-term treatment of pathological hypersecretory conditions like Zollinger-Ellison Syndrome in adults and adolescents aged 12-17.

    • esomeprazole magnesium

      (Esomeprazole Magnesium)
      Torrent Pharmaceuticals Limited
      Usage: Esomeprazole magnesium for delayed-release oral suspension is indicated for the short-term treatment of erosive esophagitis and GERD symptoms in adults and pediatric patients. It also aids in the maintenance of healing, reduces NSAID-associated gastric ulcer risk, helps eradicate H. pylori, and treats pathological hypersecretory conditions.

    • esomeprazole magnesium

      (Esomeprazole Magnesium)
      Aurobindo Pharma Limited
      Usage: Esomeprazole magnesium is indicated for the short-term treatment of erosive esophagitis, symptomatic GERD in adults and pediatric patients (12-17 years), maintenance of healing of erosive esophagitis, reducing NSAID-associated gastric ulcers, eradicating H. pylori to prevent duodenal ulcers, and long-term treatment of Zollinger-Ellison Syndrome.

    • esomeprazole magnesium

      (Esomeprazole Magnesium)
      Aurobindo Pharma Limited
      Usage: Esomeprazole magnesium for delayed-release oral suspension is indicated for healing erosive esophagitis, treating GERD symptoms, reducing NSAID-associated gastric ulcers, eradicating Helicobacter pylori to prevent duodenal ulcer recurrence, and long-term treatment of pathological hypersecretory conditions like Zollinger-Ellison Syndrome in various age groups.

    • esomeprazole magnesium

      (Esomeprazole Magnesium)
      Torrent Pharmaceuticals Limited
      Usage: Esomeprazole magnesium for delayed-release oral suspension is indicated for healing erosive esophagitis, treating symptomatic GERD, reducing NSAID-associated gastric ulcer risk, H. pylori eradication, and long-term treatment of pathological hypersecretory conditions like Zollinger-Ellison syndrome in adults and pediatric patients.

    • famotidine

      (FAMOTIDINE)
      Ascend Laboratories, LLC
      Usage: Famotidine tablets are indicated for treating active duodenal and gastric ulcers, symptomatic nonerosive gastroesophageal reflux disease (GERD), erosive esophagitis due to GERD, and pathological hypersecretory conditions in adults. They also help reduce the risk of duodenal ulcer recurrence in adults and pediatric patients 40 kg and greater.

    • famotidine

      (Famotidine)
      Upsher-Smith Laboratories, LLC
      Usage: Famotidine for oral suspension is indicated for adults to treat active duodenal and gastric ulcers, symptomatic GERD, erosive esophagitis, hypersecretory conditions, and to reduce duodenal ulcer recurrence. In pediatric patients, it treats peptic ulcer disease and GERD, including infants under one year.

    • famotidine

      (famotidine)
      Zydus Pharmaceuticals USA Inc.
      Usage: Famotidine for oral suspension is indicated for treating active duodenal and gastric ulcers, GERD (including esophagitis), and pathological hypersecretory conditions in adults. In pediatric patients, it treats peptic ulcer disease and GERD, while infants can be treated for GERD.

    • famotidine

      (Famotidine)
      Dr. Reddy's Laboratories Inc.
      Usage: Famotidine for oral suspension is indicated for adults to treat active duodenal and gastric ulcers, GERD (symptomatic and erosive), pathological hypersecretory conditions, and to reduce duodenal ulcer recurrence. In pediatric patients, it's used for peptic ulcer disease and GERD; infants can be treated for GERD.